RadNet, Inc.

NASDAQ:RDNT

Medical - Diagnostics & Research

Healthcare
$71.82 +2.90%

+$1.53 today

Market cap
$5.66B
Beta
1.39
P/E (TTM)
-295.1
EPS (TTM)
-$0.18
52W Low $50.76High $85.84

Volume 0.81M

Average 0.80M

RDNT Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

RadNet, Inc.NASDAQ: RDNT

Research & Development · Q3 FY2026 · quarter ended Sep 2026

Research & development remains negative

Q3 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMSep 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How RDNT compares with its peers on the latest reported figures

  • RDNT's LTM Sep 2026 research & development of $0 is the 6th highest of the 7 companies compared; the peer median is $27.56M.
  • Research & development amounts to 0.0% of revenue for RDNT, versus a peer median of 8.9%.
RDNT Competitors Peer median
Research & Development for RDNT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$1.32B +1.2%+7.1%6.5%
BRKRBruker CorporationLTM Jun 2026$393.5M -1.6%+18.8%11.2%
BFLYButterfly Network, Inc.LTM Mar 2026$35.88M -3.0%-25.6%34.9%
NNOXNano-X Imaging Ltd.LTM Dec 2025$19.24M -4.7%-10.1%147.7%
IRMDIRadimed CorporationLTM Mar 2026$3.31M +25.5%+9.3%3.8%
RDNTRadNet, Inc.LTM Sep 2026$0 ——0.0%
LMRILumexa Imaging Holdings, Inc. Common StockFY2025$0 ——0.0%
Peer median (excluding RDNT) $27.56M-1.6%+7.1%8.9%

Competitors are the stored peer set for RDNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.32B1.43B1.62B1.83B2.04B
Cost of Revenue1.12B1.26B1.4B1.58B1.95B
Gross Profit191.8M165.72M221.39M249.12M90.8M
Gross Margin14.6%11.6%13.7%13.6%4.5%
Research & Development00000
Selling, General & Admin00000
Operating Expenses109.25M119.35M122.69M144.49M0
Depreciation & Amortization170.66M184.72M189.49M137.84M152.13M
EBITDA278.37M278.53M292.79M262.55M253.95M
EBITDA Margin21.2%19.5%18.1%14.3%12.4%
Operating Income82.55M46.36M98.7M104.62M90.8M
Operating Margin6.3%3.2%6.1%5.7%4.5%
Interest Income00000
Interest Expense48.83M50.84M64.48M79.85M69.91M
Other Income / Expenses(23.68M)(3.39M)(59.89M)(59.76M)(58.9M)
Income Before Tax58.88M42.97M38.81M44.86M31.91M
Pre-Tax Margin4.5%3.0%2.4%2.5%1.6%
Income Tax Expense14.56M9.36M8.47M6.03M14.86M
Net Income24.73M10.65M3.04M2.79M(18.65M)
Net Margin1.9%0.7%0.2%0.2%-0.9%
EPS (Basic)0.470.190.050.04(0.25)
EPS (Diluted)0.460.170.050.04(0.25)
Weighted Avg Shares52.5M56.29M63.58M73.04M75.19M
Weighted Avg Shares (Diluted)53.42M57.32M64.66M74.76M75.19M

RadNet, Inc.

NASDAQ:RDNT

Intrinsic Alpha fair value

Locked

Current Price

$71.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.